Dr. Katzel on Why Women With Head and Neck Cancer are Undertreated

Video

Jed A. Katzel, MD, hematology, Kaiser Permanente Santa Clara Medical Center, discusses why women with head and neck cancer are undertreated.

Jed A. Katzel, MD, hematology, Kaiser Permanente Santa Clara Medical Center, discusses why women with head and neck cancer are undertreated.

A study done in Northern California found that women are more likely than men to die from head and neck cancer compared with other causes, even when generalized competing events (GCE) analysis considered tumor location and stage, states Katzel.

Compared with men, women were less likely to receive intensive chemotherapy (35% vs 46%; P = .006) and radiation (60% vs 70%; P = .008). More research needs to be done to figure out why that is the case, says Katzel.

In the analysis, researchers also found that there was a statistically significant difference in tumor location. The rate of oropharyngeal cancer in women was 38%, whereas the rate of oropharyngeal cancer in men was 55%, says Katzel. Oropharyngeal cancer is more likely to be HPV related. HPV-related head and neck cancer has a better prognosis and a better response to therapy, notes Katzel. Further research will include a chart-by-chart review as well as the upcoming NRG-HN004 clinical trial that will use the GCE model prospectively.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD